KANE JOHN A
SEC CIK 1049356 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HCAT | Health Catalyst, Inc. | Dir | 170.7K | — | — | 4 | 2022-06-14 | 2025-07-09 |
Most active insiders at HCAT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Larson-Green Julie | Dir | — | $128.2K |
| 2 | Kohl Simeon | CEO, Dir | $105.4K | — |
| 3 | Landry Benjamin | GC | — | $72.4K |
| 4 | Albert Benjamin | CEO, Dir | — | — |
| 5 | Hoggard Green Jill | Dir | — | — |
| 6 | Freeman Kevin Lee | Chief Commercial Off | — | — |
| 7 | Alger Jason | CFO | — | — |
| 8 | Burton Daniel D. | CEO, Dir | — | — |
| 9 | Gallagher Duncan | Dir | — | — |
| 10 | Llewelyn Linda | CHRO | — | — |
KANE JOHN A made no open-market trades at HCAT in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-10 | 2025-07-09 | HCAT | Health Catalyst, Inc. | KANE JOHN A | Dir | A - Grant | $0.00 | +36.2K | 170.7K | +27% | $0 | |
| 2024-06-17 | 2024-06-13 | HCAT | Health Catalyst, Inc. | KANE JOHN A | Dir | A - Grant | $0.00 | +20.8K | 131.0K | +19% | $0 | |
| M | 2023-06-16 | 2023-06-14 | HCAT | Health Catalyst, Inc. | KANE JOHN A | Dir | A - Grant | $0.00 | +22.6K | 110.2K | +26% | $0 |
| 2022-06-16 | 2022-06-14 | HCAT | Health Catalyst, Inc. | KANE JOHN A | Dir | A - Grant | $0.00 | +11.7K | 91.1K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations